Frequency specific microcurrent (FSM) therapy is a treatment that delivers extremely low-level electrical current, measured in millionths of an ampere (microamps), to the body using specific pairs of frequencies believed to target particular tissues and conditions. Unlike a TENS unit, which uses milliamp-level current strong enough to override pain signals, FSM operates at current levels so low you typically can’t feel them. The therapy is used primarily for pain, inflammation, and tissue recovery, and is offered by chiropractors, physical therapists, and some physicians as a complement to conventional treatment.
How FSM Differs From Other Electrical Therapies
The defining feature of FSM is its use of two simultaneous frequencies delivered through microampere-level current. One frequency is intended to address the condition (such as inflammation or scarring), and the other targets the tissue type (nerve, muscle, tendon, and so on). This dual-channel approach is what makes it “frequency specific,” as practitioners select from lists of frequency combinations matched to the patient’s diagnosis.
The current is delivered through conductive graphite gloves, moistened towels, or gel electrode patches placed on the skin. Because the current is roughly 1,000 times weaker than what a standard TENS unit produces, most people feel nothing during treatment. TENS works by overstimulating sensory nerves to block pain signals from reaching the brain. FSM, by contrast, is theorized to work at the cellular level, influencing tissue repair and inflammation rather than simply masking pain.
What Happens at the Cellular Level
The most frequently cited laboratory finding involves adenosine triphosphate (ATP), the molecule your cells use as fuel for repair and basic function. In rat skin studies, microcurrent in the range of 50 to 1,000 microamps increased ATP production by three to five times normal levels. Proponents argue this boost in cellular energy is what accelerates healing in damaged tissues, giving cells the resources they need to recover faster.
FSM also appears to affect the body’s inflammatory chemistry. In a study of fibromyalgia patients whose condition was linked to cervical spine trauma, 60 minutes of FSM treatment produced dramatic reductions in key inflammatory markers. Tumor necrosis factor alpha (TNF-α), a protein that amplifies pain and inflammation, dropped from 305 to 78 picograms per milliliter. Interleukin-1 and interleukin-6, two other inflammatory compounds known to increase pain sensitivity by altering how nerve cells process signals, also fell substantially. At the same time, the patients showed increases in beta-endorphin (the body’s natural painkiller) and cortisol, which helps regulate inflammation.
These are notable findings, though it’s worth understanding the context. Most FSM research involves small study populations, and the therapy lacks the large randomized controlled trials that would place it on firmer scientific footing. The cellular mechanisms are plausible but not fully established in humans at the level of rigor seen in mainstream pain medicine.
Conditions Treated With FSM
FSM is most commonly used for musculoskeletal and nerve-related pain. Practitioners treat conditions including myofascial pain (tight, painful muscle knots), fibromyalgia, nerve pain from injuries or conditions like shingles, tendon and ligament injuries, and chronic inflammation. Some practitioners also use it for concussion recovery and visceral conditions, though evidence for these applications is thinner.
A 2025 pilot randomized controlled trial tested FSM in adults with clinically significant stress and somatic symptoms (physical complaints like pain, fatigue, and tension). Participants who received FSM showed statistically significant reductions in somatic symptoms after 12 sessions. Those who received FSM combined with relaxation techniques improved even faster, showing significant improvement after just six sessions. The researchers noted that FSM produced more rapid effects than relaxation techniques alone, with earlier improvements in perceived stress and negative mood.
FSM has shown particular promise for fibromyalgia associated with spine trauma. In one study of 45 patients with this specific subtype, inflammatory markers dropped by factors of 10 to 20 after a single 60-minute session. This is a striking result, but it applies to a narrow subset of fibromyalgia patients, not the condition broadly. Practitioners emphasize that choosing the correct frequency pair for the specific tissue and condition is essential, and that the wrong frequencies simply produce no effect.
What a Session Looks Like
A typical FSM session lasts between 30 and 90 minutes. You’ll usually lie on a treatment table while the practitioner places damp towels, electrode patches, or graphite gloves on your skin. The practitioner programs two channels of frequencies into a device roughly the size of a portable radio, selecting combinations based on your diagnosis. You won’t feel the current. Some people report a sensation of warmth, relaxation, or softening in the treated area during the session, while others notice nothing until afterward.
Hydration matters for FSM. The electrical current travels through water in your tissues, so practitioners typically ask patients to drink extra water before and after sessions. Dehydrated tissue conducts current poorly, which can reduce the therapy’s effectiveness. How many sessions you’ll need depends on the condition. Acute injuries may respond in one to three visits, while chronic pain conditions like fibromyalgia often require ongoing treatment over weeks or months.
FDA Status and Safety Profile
Microcurrent devices are classified by the FDA as Class II medical devices under the same regulatory category as transcutaneous electrical nerve stimulators. This means the devices themselves have been cleared for sale, but the FDA has not specifically evaluated or approved the frequency-specific protocols that define FSM as a distinct therapy. The clearance covers the hardware, not the clinical claims.
FSM has a favorable safety profile. Because the current is so low, side effects are uncommon. The most frequently reported issue is a temporary feeling of fatigue or nausea after treatment, which practitioners attribute to the release of inflammatory byproducts as tissues respond. According to Cleveland Clinic, providers typically avoid FSM in patients who have a pacemaker, an implanted pump (such as an insulin or baclofen pump), a seizure disorder, or are pregnant. These precautions are largely borrowed from general electrotherapy guidelines rather than specific adverse events reported with FSM.
Limitations of the Evidence
The honest picture of FSM is that the clinical results are promising but preliminary. Most published studies are small, and many come from practitioners with a direct stake in the therapy’s adoption. The cytokine reduction data, while statistically significant, has not been replicated in large independent trials. The ATP findings come from animal models, and it’s not yet clear how directly those results translate to human tissue at the depths where injuries typically occur.
There is also no standardized training or credentialing body for FSM practitioners, which means the quality of treatment can vary significantly depending on who is delivering it. Some practitioners have extensive clinical experience and track outcomes carefully, while others may apply protocols more loosely. If you’re considering FSM, looking for a provider who has completed formal FSM training courses and who treats your specific condition regularly is a reasonable way to improve your odds of a good outcome.